Literature DB >> 23828950

Factors affecting the clinical use of non-invasive prenatal testing: a mixed methods systematic review.

Heather Skirton1, Christine Patch.   

Abstract

Non-invasive prenatal testing has been in clinical use for a decade; however, there is evidence that this technology will be more widely applied within the next few years. Guidance is therefore required to ensure that the procedure is offered in a way that is evidence based and ethically and clinically acceptable. We conducted a systematic review of the current relevant literature to ascertain the factors that should be considered when offering non-invasive prenatal testing in a clinical setting. We undertook a systematic search of relevant databases, journals and reference lists, and from an initial list of 298 potential papers, identified 11 that were directly relevant to the study. Original data were extracted and presented in a table, and the content of all papers was analysed and presented in narrative form. Four main themes emerged: perceived attributes of the test, regulation and ethical issues, non-invasive prenatal testing in practice and economic considerations. However, there was a basic difference in the approach of actual or potential service users, who were very positive about the benefits of the technology, compared with other research participants, who were concerned with the potential moral and ethical outcomes of using this testing method. Recommendations for the appropriate use of non-invasive prenatal testing are made.

Entities:  

Mesh:

Year:  2013        PMID: 23828950     DOI: 10.1002/pd.4094

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  10 in total

1.  Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?

Authors:  Caroline Silcock; Lih-Mei Liao; Melissa Hill; Lyn S Chitty
Journal:  Health Expect       Date:  2014-02-20       Impact factor: 3.377

2.  Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives.

Authors:  Elizabeth Alexander; Susan Kelly; Lauren Kerzin-Storrar
Journal:  J Genet Couns       Date:  2014-10-15       Impact factor: 2.537

Review 3.  How should costs and cost-effectiveness be considered in prenatal genetic testing?

Authors:  Teresa N Sparks; Aaron B Caughey
Journal:  Semin Perinatol       Date:  2018-07-26       Impact factor: 3.300

4.  Global perspectives on clinical adoption of NIPT.

Authors:  Mollie A Minear; Celine Lewis; Subarna Pradhan; Subhashini Chandrasekharan
Journal:  Prenat Diagn       Date:  2015-09-25       Impact factor: 3.050

5.  Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis.

Authors:  Melissa Hill; Cecilia Compton; Madhavi Karunaratna; Celine Lewis; Lyn Chitty
Journal:  J Genet Couns       Date:  2014-05-03       Impact factor: 2.537

6.  Direct to consumer testing in reproductive contexts--should health professionals be concerned?

Authors:  Heather Skirton
Journal:  Life Sci Soc Policy       Date:  2015-04-29

7.  Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong.

Authors:  Huso Yi; Nina Hallowell; Sian Griffiths; Tak Yeung Leung
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

Review 8.  Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues.

Authors:  Jean Gekas; Sylvie Langlois; Vardit Ravitsky; François Audibert; David Gradus van den Berg; Hazar Haidar; François Rousseau
Journal:  Appl Clin Genet       Date:  2016-02-04

9.  Offering prenatal diagnostic tests: European guidelines for clinical practice [corrected].

Authors:  Heather Skirton; Lesley Goldsmith; Leigh Jackson; Celine Lewis; Lyn Chitty
Journal:  Eur J Hum Genet       Date:  2013-09-11       Impact factor: 4.246

10.  Offering non-invasive prenatal testing as part of routine clinical service. Can high levels of informed choice be maintained?

Authors:  Celine Lewis; Melissa Hill; Lyn S Chitty
Journal:  Prenat Diagn       Date:  2017-10-17       Impact factor: 3.050

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.